IBCN 2018: RBM10: A New Bladder Tumor Suppressor Gene Involved in Alternative Splicing
In conclusion, these studies will provide an understanding of the mechanisms through which RBM10 contributes to disease and pave the way to identify therapies for RBM10-mutant tumors.
Presented by: Ana M Maldonado-Barragán, National Center of Cancer Research, Spain
Written by: Stephen B. Williams, M.D., Associate Professor, Division of Urology, The University of Texas Medical Branch, Galveston, TX. and Ashish M. Kamat, M.D. Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX at the 16th Annual Meeting of the International Bladder Cancer Network (IBCN) October 11-13, 2018 - the Inntel Hotels Rotterdam Centre, Rotterdam, The Netherlands